Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-01-24 00:00:00 ET · period of report 2024-01-22 · accession 0001610717-24-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-01-24 | 2024-01-22 | RVMD | Cislini Jeff | GC | S - Sale | $27.00 | -1,500 | 36.1K | -4% | -$40.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-22 | S | D | 1,500 | $27.00 | 36,126 | D | — | — | (F3) Includes 342 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023. (F2) Includes 31,417 restricted stock units. |